ClinicalTrials.govpublic full text
Natriuretic Peptide System as Therapy in Human Preclinical Left Ventricle Dysfunction
congestive heart failure, heart failure, diastolic dysfunction, systolic dysfunction, preclinical, natriuretic peptide, b-type natriuretic peptide, cyclic guanosine monophosphate, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 858272
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.